Browsing by Author "Sipahi, Ilke"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
Item A Comparison of Results of the US Food and Drug Administration's Mini-Sentinel Program With Randomized Clinical Trials: The Case of Gastrointestinal Tract Bleeding With Dabigatran(AMER MEDICAL ASSOC, 2014-01-01) Sipahi, Ilke; Celik, Seden; Tozun, NurdanItem Dabigatran's `Real-World' Data About Risk of Myocardial Infarction and Gastrointestinal Bleeding Contradicts With Randomized Trials(ELSEVIER SCIENCE INC, 2013-01-01) Sipahi, Ilke; Celik, Seden; Akyol, AhmetItem QRS Duration Criteria to Select Patients for Cardiac Resynchronization Therapy CRT Should Be Reserved for a QRS Duration >= 150 ms: Pro(LIPPINCOTT WILLIAMS \& WILKINS, 2013-01-01) Sipahi, Ilke; Fang, James C.Item Risk of cancer with angiotensin-receptor blockers increases with increasing cumulative exposure: Meta-regression analysis of randomized trials(PUBLIC LIBRARY SCIENCE, 2022-01-01) Sipahi, IlkeAngiotensin-receptor blockers (ARBs) are a class of drugs approved for the treatment of several common conditions, such as hypertension and heart failure. Recently, regulatory agencies have started to identify possibly carcinogenic nitrosamines and azido compounds in a multitude of formulations of several ARBs, resulting in progressive recalls. Furthermore, data from several randomized controlled trials suggested that there is also a clinically increased risk of cancer and specifically lung cancer with ARBs